Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates

Trypanosoma cruzi, the agent of Chagas disease, probably infects tens of millions of people, primarily in Latin America, causing morbidity and mortality. The options for treatment and prevention of Chagas disease are limited and underutilized. Here we describe the discovery of a series of benzoxabor...

Descripción completa

Detalles Bibliográficos
Autores principales: Padilla, Angel M., Wang, Wei, Akama, Tsutomu, Carter, David S., Easom, Eric, Freund, Yvonne, Halladay, Jason S., Liu, Yang, Hamer, Sarah A., Hodo, Carolyn L., Wilkerson, Gregory K., Orr, Dylan, White, Brooke, George, Arlene, Shen, Huifeng, Jin, Yiru, Wang, Michael Zhuo, Tse, Susanna, Jacobs, Robert T., Tarleton, Rick L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519446/
https://www.ncbi.nlm.nih.gov/pubmed/36065062
http://dx.doi.org/10.1038/s41564-022-01211-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519446/
https://www.ncbi.nlm.nih.gov/pubmed/36065062
http://dx.doi.org/10.1038/s41564-022-01211-y

Ejemplares similares